Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rajalakshmi Govalan"'
Autor:
Sameer K. Berry, Will Takakura, Devin Patel, Rajalakshmi Govalan, Afsoon Ghafari, Elizabeth Kiefer, Shao-Chi Huang, Catherine Bresee, Teryl K. Nuckols, Gil Y. Melmed
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Most hospitalized patients with inflammatory bowel disease (IBD) experience pain. Despite the known risks associated with opioids in IBD including risk for misuse, overdose, infection, readmission, and even death, opioid use is more prevalen
Externí odkaz:
https://doaj.org/article/4120126faba44f6e944b316dd0f315d6
Autor:
Rajalakshmi Govalan, Michael Luu, Marie Lauzon, Kambiz Kosari, Joseph C. Ahn, Nicole E Rich, Nicholas Nissen, Lewis R. Roberts, Amit G. Singal, Ju Dong Yang
Publikováno v:
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Prognosis of hepatocellular carcinoma (HCC) could be affected by lack of or delayed therapy. We aimed to characterize the prevalence, correlates, and clinical impact of therapeutic underuse and delay in patients with HCC. Patients with HCC diagnosed
Externí odkaz:
https://doaj.org/article/712d6ece924040768eecc187834a5741
Autor:
Rajalakshmi Govalan, Marie Lauzon, Michael Luu, Joseph C. Ahn, Kambiz Kosari, Tsuyoshi Todo, Irene K. Kim, Mazen Noureddin, Alexander Kuo, Ayoub S. Walid, Vinay Sundaram, Shelly C. Lu, Lewis R. Roberts, Amit G. Singal, Julie K. Heimbach, Vatche G. Agopian, Nicholas Nissen, Ju Dong Yang
Publikováno v:
Liver Cancer, Pp 1-12 (2021)
Introduction: Small studies from outside of the USA suggest excellent outcomes after surgical resection for hepatocellular carcinoma (HCC) with vascular invasion. The study aims to (1) compare overall survival after surgical resection and systemic th
Externí odkaz:
https://doaj.org/article/467b06b0f4aa4d66b2f0c0188fccf32d
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 479 (2021)
Globally, hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is one of the major causes of cancer-related mortality. This is, in part, due to delayed diagnosis and limited therapeutic options with more advanced stages of the disease. Give
Externí odkaz:
https://doaj.org/article/dbc41d8c27954e08ac2804fac5bad4ed
Autor:
Joseph C. Ahn, Rajalakshmi Govalan, Lewis R. Roberts, Marie Lauzon, Nicole E. Rich, Kambiz Kosari, Nicholas N. Nissen, Ju Dong Yang, Michael Luu, Amit G. Singal
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Hepatology Communications, Vol 6, Iss 1, Pp 223-236 (2022)
Prognosis of hepatocellular carcinoma (HCC) could be affected by lack of or delayed therapy. We aimed to characterize the prevalence, correlates, and clinical impact of therapeutic underuse and delay in patients with HCC. Patients with HCC diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824acf2b7168327ed488c1f612327f6c
https://doi.org/10.1002/hep4.1795
https://doi.org/10.1002/hep4.1795
Autor:
Nicholas N. Nissen, Vinay Sundaram, Shelly C. Lu, Irene K. Kim, Amit G. Singal, Ayoub S. Walid, Michael Luu, Ju Dong Yang, Joseph C. Ahn, Alexander Kuo, Marie Lauzon, Vatche G. Agopian, Lewis R. Roberts, Julie K. Heimbach, Rajalakshmi Govalan, Mazen Noureddin, Tsuyoshi Todo, Kambiz Kosari
Publikováno v:
Liver Cancer, Pp 1-12 (2021)
Liver Cancer
Liver cancer, vol 10, iss 5
Liver Cancer
Liver cancer, vol 10, iss 5
Introduction: Small studies from outside of the USA suggest excellent outcomes after surgical resection for hepatocellular carcinoma (HCC) with vascular invasion. The study aims to (1) compare overall survival after surgical resection and systemic th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::facbf26d2e786f5caa94aa9c53da5469
https://doi.org/10.1159/000515554
https://doi.org/10.1159/000515554
Autor:
Sameer Berry, Will Takakura, Devin Patel, Rajalakshmi Govalan, Afsoon Ghafari, Elizabeth Kiefer, Shao-Chi Huang, Catherine Bresee, Teryl K. Nuckols, Gil Y. Melmed
Background: Most hospitalized patients with inflammatory bowel disease (IBD) experience pain. Despite the known risks associated with opioids in IBD including risk for misuse, overdose, infection, readmission, and even death, opioid use is more preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f75d7c1561aa357b93b44969feee4f37
https://doi.org/10.21203/rs.3.rs-1471840/v1
https://doi.org/10.21203/rs.3.rs-1471840/v1
Publikováno v:
Gastroenterology. 161:e4-e5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bcfe5b78f93d81612916bd87e1e00e5
https://doi.org/10.1053/j.gastro.2021.03.057
https://doi.org/10.1053/j.gastro.2021.03.057
Publikováno v:
American Journal of Gastroenterology. 116:S1157-S1157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9819ac3cc486deaec4f462c9fa77c8da
https://doi.org/10.14309/01.ajg.0000784632.69597.14
https://doi.org/10.14309/01.ajg.0000784632.69597.14
Autor:
Will Takakura, Catherine Bresee, Afsoon Ghafari, Gil Y. Melmed, Elizabeth Kiefer, Rajalakshmi Govalan, Shao-Chi Huang, Devin Patel, Sameer K. Berry, Teryl K. Nuckols
Publikováno v:
American Journal of Gastroenterology. 115:S403-S404
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::063e2d5fa84a8bbcbf4faf938f884f8a
https://doi.org/10.14309/01.ajg.0000705208.52566.10
https://doi.org/10.14309/01.ajg.0000705208.52566.10